World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P. falciparum malaria transmission. The recommendation is based on results from an ongoing pilot programme in Ghana, Kenya & Malawi that has reached more than 800 000 children since 2019.
The vaccine is developed by British drugmaker GlaxoSmithKline (GSK). Many vaccines exist against viruses and bacteria but this was the first time that the WHO recommended broad use of a vaccine against a human parasite. The vaccine acts against Plasmodium falciparum, one of five parasite species and the most deadly. The symptoms of malaria are fever, headaches, and muscle pain, then cycles of chills, fever, and sweating.
Important takeaways for all competitive exams:
India has decided not to host the 33rd Conference of Parties (COP33) in 2028, even…
Indian-origin scientist Deep Jariwala has been selected for one of the most respected research roles…
In a recent academic event, Birla Institute of Management Technology (BIMTECH), Greater Noida, successfully organized…
The famous TCS World 10k Bengaluru race will take place on 26 April 2026, and…
India lost a senior and respected political leader on April 8, 2026, as Mohsina Kidwai…
India has taken another strong step in boosting its defense power with the silent commissioning…